| Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms G Venton, F Courtier, A Charbonnier, E D'incan, C Saillard, B Mohty, ... American journal of hematology 93 (3), 330-338, 2018 | 70 | 2018 |
| Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation D Luque Paz, R Jouanneau-Courville, J Riou, JC Ianotto, F Boyer, ... Blood advances 4 (19), 4887-4897, 2020 | 59 | 2020 |
| Genomic analysis of myeloproliferative neoplasms in chronic and acute phases F Courtier, N Carbuccia, S Garnier, A Guille, J Adélaïde, N Cervera, ... Haematologica 102 (1), e11, 2017 | 50 | 2017 |
| Targeted molecular characterization shows differences between primary and secondary myelofibrosis F Courtier, S Garnier, N Carbuccia, A Guille, J Adélaide, M Chaffanet, ... Genes, Chromosomes and Cancer 59 (1), 30-39, 2020 | 24 | 2020 |
| A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study A Collignon, MA Hospital, C Montersino, F Courtier, A Charbonnier, ... Blood Cancer Journal 10 (6), 64, 2020 | 22 | 2020 |
| Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis A Wanquet, F Courtier, A Guille, N Carbuccia, S Garnier, J Adélaide, ... Leukemia & Lymphoma 60 (5), 1289-1293, 2019 | 7 | 2019 |
| A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome GC Wagner A, Rouleau M, Villeneuve L, Le T, Peltier C, Allain ÉP, Beaudoin C ... Cells, 2023 | 2 | 2023 |
| Investigation of molecular features involved in clinical responses and survival in advanced endometrial carcinoma treated by hormone therapy M Neron, A Guille, L Allegre, PE Colombo, C Leaha, J Adelaide, ... Journal of Personalized Medicine 12 (5), 655, 2022 | 2 | 2022 |
| A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome. Cells 2023, 12, 1295 A Wagner, M Rouleau, L Villeneuve, T Le, C Peltier, ÉP Allain, ... | | 2023 |
| Caractérisation moléculaire des néoplasies myéloprolifératives et de leur transformation en leucémie aigüe myéloïde| Theses. fr F Courtier Aix-Marseille, 2019 | | 2019 |
| LEUKEMIC TRANSFORMATION OF MYELOPROLIFERATIVE NEOPLASMS: IS NGS PROFILE THE BEST PROGNOSTIC BIOMARKER? V Geoffroy, F Courtier, A Charbonnier, E D'Incan, C Saillard, B Mohty, ... HAEMATOLOGICA 102, 119-119, 2017 | | 2017 |
